IL18 and cancer: However, our findings challenge the conventional understanding of pyroptosis in cancer immunotherapy by demonstrating a GSDME-independent mechanism of tumour cell death with retained immunostimulatory features, including IL-18 secretion, although further investigation is needed to confirm current findings.